Did Jisandai (Bingtonsha) relapse after three months of treatment? Coping strategies and precautions

Epclusa (Epclusa), as a compound drug containing Sofosbuvir (Sofosbuvir) and Velpatasvir (Velpatasvir), is widely used to treat chronic hepatitis B and shows good efficacy in most patients. However, some patients may experience recurrence of their condition after three months of treatment with Bingtongsha. This phenomenon requires special attention and proper handling.

Faced with recurrence after treatment with Jisandai (Bingtonsha), the patient's first priority is to undergo a comprehensive medical examination. Doctors will recommend that patients undergo a viral load test to determine whether the virus is still present and to assess the mutation status of the virus. Relapse may result from viral mutation, increased drug tolerance, or other unknown factors. Understanding the specifics of the virus is critical to developing treatment options.

Another possible cause of relapse is treatment compliance issues. Patients need to ensure that they take their medications strictly as directed by their doctor and avoid missing doses or using medications in a manner not recommended by their doctor. Any deviation from medical advice may weaken the effectiveness of treatment and increase the risk of recurrence. If the patient has missed taking medication, he should communicate with his doctor and try to avoid such problems in subsequent treatment.

If it is determined that the relapse is not due to treatment compliance issues, the doctor may consider adjusting the treatment plan. This may include switching to other antiviral medications, or combining other medications to enhance the effectiveness of treatment. Based on the patient's specific situation, the doctor may recommend different treatment options, such as choosing other drug combinations or extending the treatment cycle.

For patients who relapse, regular follow-up and monitoring are equally important. Doctors will regularly check the patient's liver function and viral load to evaluate the treatment effect and adjust the treatment plan in a timely manner. This helps ensure patients receive the most effective treatment and minimize the risk of recurrence. To sum up, in the face of recurrence after treatment with Jisanda (Bingtonsha), patients should work closely with their doctors to conduct a comprehensive examination, explore possible causes, and formulate personalized treatment strategies in order to achieve the best treatment effect.